The relationship between cholesterol and survival in patients with chronic heart failure
Mathias Rauchhaus, MD* ,
Andrew L. Clark, MD ,*,
Wolfram Doehner, MD*,
Constantinos Davos, MD, PhD*,
Aidan Bolger, BSc*,
Rakesh Sharma, BSc*,
Andrew J. S. Coats, DM* and
Stefan D. Anker, MD, PhD*
* Clinical Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom
Klinik und Poliklinik für Innere Medizin III, Martin-Luther-Universität, Halle, Germany
Academic Cardiology, Castle Hill Hospital, Hull, United Kingdom
Franz-Volhard-Klinik (Charité, Campus Berlin-Buch) am Max-Delbrück Centrum für Molekulare Medizin, Berlin, Germany

View larger version (24K):
[in a new window]
|
Figure 1 Survival in the derivation study with patients classified into quartiles of total cholesterol (quartile 1 being the lowest; 4 the highest). Log-rank p = 0.0016 for the differences between quartiles.
|
|

View larger version (15K):
[in a new window]
|
Figure 2 Survival in the validation study related to the best predictive value for serum cholesterol found in the derivation study. Log-rank p = 0.0011 for the difference between groups.
|
|

View larger version (23K):
[in a new window]
|
Figure 3 Survival by etiology and cholesterol in the validation study. Log-rank p = 0.05 for comparison between high and low cholesterol in nonischemic etiology and p = 0.001 for ischemic etiology.
|
|
|